Immediate Impact

1 by Nobel laureates 2 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
1 intermediate paper

Works of Millicent Embry being referenced

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001
2018

Author Peers

Author Last Decade Papers Cites
Millicent Embry 281 224 38 147 11 413
Xiaoman Lewis 351 81 32 137 9 485
Raymond E. Meyn 237 142 85 49 15 384
Sandrina Phipps 278 129 99 160 11 407
Sanaa T. Dergham 174 314 36 39 11 450
S. O. Yim 316 163 45 74 9 496
Bos Jl 256 118 15 68 13 389
Phillip H. Koeffler 334 205 16 55 13 465
Shi-Rong Cai 223 89 14 119 12 438
Carlo Avignolo 215 191 35 104 13 374
Roshini M. Ponnamperuma 319 226 10 40 12 474

All Works

Loading papers...

Rankless by CCL
2026